Clearmind Medicine Inc. (CMND)

NASDAQ: CMND · IEX Real-Time Price · USD

1.580

-0.080 (-4.82%)

At close: Jul 2, 2024, 4:00 PM

1.620

+0.040 (2.53%)

After-hours: Jul 2, 2024, 7:59 PM EDT

Clearmind Medicine Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Year	Current	2023	2022
Market Capitalization	5	1	-
Market Cap Growth	173.68%	-	-
Enterprise Value	-1	-5	-0
PE Ratio	-	-0.10	-
PB Ratio	1.47	0.88	-
P/FCF Ratio	-0.79	-0.14	-
P/OCF Ratio	-0.79	-0.14	-
EV/EBITDA Ratio	0.68	0.54	0.04
EV/EBIT Ratio	0.68	0.54	0.04
EV/FCF Ratio	0.95	0.74	0.08
Debt / Equity Ratio	-	-	-0.03
Debt / EBITDA Ratio	-	-	-0.01
Debt / FCF Ratio	-	-	-0.01
Quick Ratio	1.99	1.13	0.19
Current Ratio	2.07	1.17	0.23
Return on Equity (ROE)	-205.10%	-280.40%	-373.10%
Return on Assets (ROA)	-94.20%	-152.20%	-230.40%
Return on Capital (ROIC)	-118.43%	-640.94%	585.55%
Earnings Yield	-138.20%	-993.52%	-
FCF Yield	-69.87%	-726.22%	-
Buyback Yield / Dilution	-2504.47%	-367.25%	-40.19%
Total Shareholder Return	-2504.47%	-367.25%	-40.19%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).